CoChat

Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels

Open access
Kovamees, O., Shemyakin, A., Eriksson, M., Angelin, B., Pernow, J. · 2016 · Journal of Internal Medicine
Cited by 48

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: Elevated LDL cholesterol is an important risk factor for atherosclerosis. Endothelial dysfunction, an early event in the development of atherosclerosis, is characterized by a reduction in nitric oxide (NO) bioavailability. Arginase has emerged as a key regulator of endothelial function through competition with NO synthase for the common substrate l‐arginine. Arginase in endothelial cells is activated by oxidized LDL. The study aim was to investigate the importance of arginase for endothelial dysfunction in patients with familial hypercholesterolaemia (FH). Methods and results: Endothelial function was evaluated in 12 patients with heterozygous FH and 12 age‐matched healthy normocholesterolaemic subjects using forearm venous occlusion plethysmography. The evaluations in FH patients occurred when they were on lipid‐lowering therapy and 4 weeks after withdrawal of treatment. Endothelium‐dependent vasodilatation (EDV) was assessed by intrabrachial artery infusion of serotonin, and endothelium‐independent dilatation was assessed by infusion of nitroprusside before and after 120 min administration of the arginase inhibitor N ω‐hydroxy‐nor‐l‐arginine (nor‐NOHA; 0.1 mg min−1). In FH patients LDL cholesterol increased from 4.3 ± 0.9 mmol L−1 at baseline to 7.6 ± 1.9 mmol L−1 at follow‐up (P < 0.001). Arginase inhibition enhanced EDV in FH patients by a similar degree independent of lipid‐lowering therapy. The improvement in EDV by arginase inhibition was significantly greater in FH patients than in the control group. Conclusion: Arginase inhibition results in greater improvement in endothelial function in patients with FH compared to healthy controls irrespective of their cholesterol levels. Arginase may be a promising therapeutic target for improving endothelial function in patients with hypercholesterolaemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/joim.12461

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 48

Metadata

Authors
Kovamees, O., Shemyakin, A., Eriksson, M., Angelin, B., & Pernow, J.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2015-12-28
Volume
279
Issue
5
Pages
477-484
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2211415242
Cited by
48
References
6
FWCI
3.23
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels. https://app.cochat.ai/papers/10.1111/joim.12461
The paper
Kovamees, O., Shemyakin, A., Eriksson, M., Angelin, B., & Pernow, J. (2016). Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels. Journal of Internal Medicine. https://doi.org/10.1111/joim.12461

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.